188 related articles for article (PubMed ID: 17329846)
1. Identification of new small molecule inhibitors of cystic fibrosis transmembrane conductance regulator protein: in vitro and in vivo studies.
Muanprasat C; Kaewmokul S; Chatsudthipong V
Biol Pharm Bull; 2007 Mar; 30(3):502-7. PubMed ID: 17329846
[TBL] [Abstract][Full Text] [Related]
2. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor.
Thiagarajah JR; Broadbent T; Hsieh E; Verkman AS
Gastroenterology; 2004 Feb; 126(2):511-9. PubMed ID: 14762788
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.
Ma T; Thiagarajah JR; Yang H; Sonawane ND; Folli C; Galietta LJ; Verkman AS
J Clin Invest; 2002 Dec; 110(11):1651-8. PubMed ID: 12464670
[TBL] [Abstract][Full Text] [Related]
4. Antidiarrheal efficacy of a quinazolin CFTR inhibitor on human intestinal epithelial cell and in mouse model of cholera.
Patanayindee J; Muanprasat C; Soodvilai S; Chatsudthipong V
Indian J Pharmacol; 2012; 44(5):619-23. PubMed ID: 23112425
[TBL] [Abstract][Full Text] [Related]
5. A plant-derived hydrolysable tannin inhibits CFTR chloride channel: a potential treatment of diarrhea.
Wongsamitkul N; Sirianant L; Muanprasat C; Chatsudthipong V
Pharm Res; 2010 Mar; 27(3):490-7. PubMed ID: 20225391
[TBL] [Abstract][Full Text] [Related]
6. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease.
Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 22186622
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents.
Sonawane ND; Muanprasat C; Nagatani R; Song Y; Verkman AS
J Pharm Sci; 2005 Jan; 94(1):134-43. PubMed ID: 15761937
[TBL] [Abstract][Full Text] [Related]
8. CFTR chloride channel as a molecular target of anthraquinone compounds in herbal laxatives.
Yang H; Xu LN; He CY; Liu X; Fang RY; Ma TH
Acta Pharmacol Sin; 2011 Jun; 32(6):834-9. PubMed ID: 21602836
[TBL] [Abstract][Full Text] [Related]
9. Activation of AMP-activated protein kinase by a plant-derived dihydroisosteviol in human intestinal epithelial cell.
Muanprasat C; Sirianant L; Sawasvirojwong S; Homvisasevongsa S; Suksamrarn A; Chatsudthipong V
Biol Pharm Bull; 2013; 36(4):522-8. PubMed ID: 23343619
[TBL] [Abstract][Full Text] [Related]
10. Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating.
Pedemonte N; Sonawane ND; Taddei A; Hu J; Zegarra-Moran O; Suen YF; Robins LI; Dicus CW; Willenbring D; Nantz MH; Kurth MJ; Galietta LJ; Verkman AS
Mol Pharmacol; 2005 May; 67(5):1797-807. PubMed ID: 15722457
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cAMP-activated intestinal chloride secretion by diclofenac: cellular mechanism and potential application in cholera.
Pongkorpsakol P; Pathomthongtaweechai N; Srimanote P; Soodvilai S; Chatsudthipong V; Muanprasat C
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3119. PubMed ID: 25188334
[TBL] [Abstract][Full Text] [Related]
12. Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid loss in cholera.
Sonawane ND; Hu J; Muanprasat C; Verkman AS
FASEB J; 2006 Jan; 20(1):130-2. PubMed ID: 16317066
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CFTR-mediated intestinal chloride secretion by a fungus-derived arthropsolide A: Mechanism of action and anti-diarrheal efficacy.
Akrimajirachoote N; Satitsri S; Sommart U; Rukachaisirikul V; Muanprasat C
Eur J Pharmacol; 2020 Oct; 885():173393. PubMed ID: 32712094
[TBL] [Abstract][Full Text] [Related]
14. Identification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from chinese medicinal plants.
Zhang Y; Yu B; Sui Y; Gao X; Yang H; Ma T
PLoS One; 2014; 9(4):e94302. PubMed ID: 24714160
[TBL] [Abstract][Full Text] [Related]
15. High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening.
Ma T; Vetrivel L; Yang H; Pedemonte N; Zegarra-Moran O; Galietta LJ; Verkman AS
J Biol Chem; 2002 Oct; 277(40):37235-41. PubMed ID: 12161441
[TBL] [Abstract][Full Text] [Related]
16. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy.
Muanprasat C; Sonawane ND; Salinas D; Taddei A; Galietta LJ; Verkman AS
J Gen Physiol; 2004 Aug; 124(2):125-37. PubMed ID: 15277574
[TBL] [Abstract][Full Text] [Related]
17. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
[TBL] [Abstract][Full Text] [Related]
18. Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.
Bijvelds MJ; Bot AG; Escher JC; De Jonge HR
Gastroenterology; 2009 Sep; 137(3):976-85. PubMed ID: 19454284
[TBL] [Abstract][Full Text] [Related]
19. CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.
Verkman AS; Lukacs GL; Galietta LJ
Curr Pharm Des; 2006; 12(18):2235-47. PubMed ID: 16787252
[TBL] [Abstract][Full Text] [Related]
20. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating.
Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
